Targeting the Hippo pathway in cancer, fibrosis, wound healing and regenerative medicine

A Dey, X Varelas, KL Guan - Nature reviews Drug discovery, 2020 - nature.com
The Hippo pathway is an evolutionarily conserved signalling pathway with key roles in
organ development, epithelial homeostasis, tissue regeneration, wound healing and …

Hippo signalling in the liver: role in development, regeneration and disease

JO Russell, FD Camargo - Nature reviews Gastroenterology & …, 2022 - nature.com
The Hippo signalling pathway has emerged as a major player in many aspects of liver
biology, such as development, cell fate determination, homeostatic function and …

[HTML][HTML] Emerging role of tumor cell plasticity in modifying therapeutic response

S Qin, J Jiang, Y Lu, EC Nice, C Huang… - Signal transduction and …, 2020 - nature.com
Resistance to cancer therapy is a major barrier to cancer management. Conventional views
have proposed that acquisition of resistance may result from genetic mutations. However …

YAP and TAZ: a signalling hub of the tumour microenvironment

F Zanconato, M Cordenonsi, S Piccolo - Nature Reviews Cancer, 2019 - nature.com
YAP and TAZ are transcriptional activators pervasively induced in several human solid
tumours and their functions in cancer cells are the focus of intense investigation. These …

Extracellular vesicles in fatty liver promote a metastatic tumor microenvironment

Z Wang, SY Kim, W Tu, J Kim, A Xu, YM Yang… - Cell Metabolism, 2023 - cell.com
Liver metastasis is a major cause of death in patients with colorectal cancer (CRC). Fatty
liver promotes liver metastasis, but the underlying mechanism remains unclear. We …

YAP/TAZ signaling and resistance to cancer therapy

CDK Nguyen, C Yi - Trends in cancer, 2019 - cell.com
Drug resistance is a major challenge in cancer treatment. Emerging evidence indicates that
deregulation of YAP/TAZ signaling may be a major mechanism of intrinsic and acquired …

[HTML][HTML] Immunotherapy in treating EGFR-mutant lung cancer: current challenges and new strategies

KKW To, W Fong, WCS Cho - Frontiers in Oncology, 2021 - frontiersin.org
Lung cancer is the leading cause of cancer-related deaths worldwide. Immune checkpoint
inhibitors, including monoclonal antibodies against programmed death-1 (PD-1) and …

[HTML][HTML] The intracellular signalosome of PD-L1 in cancer cells

D Escors, M Gato-Cañas, M Zuazo, H Arasanz… - Signal transduction and …, 2018 - nature.com
Abstract Programmed cell death-1 ligand-1 (PD-L1) overexpression in cancer cells
accelerates tumor progression. PD-L1 possesses two main pro-oncogenic functions. First …

[HTML][HTML] Regulation of TEAD transcription factors in cancer biology

HD Huh, DH Kim, HS Jeong, HW Park - Cells, 2019 - mdpi.com
Transcriptional enhanced associate domain (TEAD) transcription factors play important roles
during development, cell proliferation, regeneration, and tissue homeostasis. TEAD …

[HTML][HTML] Epidermal growth factor receptor (EGFR) pathway, yes-associated protein (YAP) and the regulation of programmed death-ligand 1 (PD-L1) in non-small cell …

PC Hsu, DM Jablons, CT Yang, L You - International journal of molecular …, 2019 - mdpi.com
The epidermal growth factor receptor (EGFR) pathway is a well-studied oncogenic pathway
in human non-small cell lung cancer (NSCLC). A subset of advanced NSCLC patients (15 …